Clostridium septicumによる死滅性ファシエチスを持つ若年期急性リンパ性白血病患者のVA ECMOが成功しました
Jenna Miller1,2, Johanna Orrick1,2, Caroline Holton1,2
1Division of Critical Care, Children's Mercy Hospital, Kansas City, MO, USA.
Archive of clinical cases
|August 22, 2025
まとめ
外体膜酸素療法 (ECMO) は重症の小児腫瘍患者の命を救う治療法である. このケースは,急性リンパ性白血病と死滅性ファシイトの患者でECMOの成功例を示しています.
科学分野:
- 心血管科学
- 腫瘍学
- 感染症
背景:
- 外体膜酸素化 (ECMO) は安全性上の懸念から,がん患者では慎重に適用されています.
- クラストリジウム・セプティカムによって引き起こされる死滅性ファシイチスは,特に悪性腫瘍を有する患者において,著しい死亡リスクをもたらします.
- 併発性ネクロチズ・ファシイチスと血液性悪性腫瘍の患者に対するECMOアウトカムに関するデータは限られている.
研究 の 目的:
- 急性リンパ性白血病 (ALL) と *Clostridium septicum* のネクロチズファシイチスを持つ青少年における静脈動脈 (VA) ECMO サポートの成功例を提示する.
- 複雑な腫瘍や感染症の症例におけるECMOの実現性と成果を強調する.
主な方法:
- B細胞前 ALL と *C. septum* の死滅性ファシイチスを持つ16歳の男性は,体外心肺蘇生 (ECPR) を通して静脈動脈 ECMO を受けました.
- ECMO治療中に誘導化学療法,手術による脱皮,腹部傷の治療を受けた.
- 管理には多学科の協力と 胃腸出血のような合併症の 積極的な治療が必要でした
主要な成果:
- 患者は8日後にECMOから脱出することができました.
- 彼はよく回復し,化学療法を再開し,ALLの完全寛解と良好な機能回復で退院しました.
- 解禁後の出血の再発は観察されなかった.
結論:
- ECMOは,ネクロチズ・ファシイトのような重症な感染症の小児がん患者で成功的に使用できます.
- 患者を慎重に選択し,多学科ケアを行い,積極的な合併症管理を行うことは,好ましい結果を得るために不可欠です.
- ECMOの候補は,高リスクの介入を必要とする患者でも個別化されるべきです.
関連する概念動画
Acute Respiratory Failure-II
360
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
360
Acute Respiratory Failure-V
205
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
205
Acute Respiratory Failure-IV
228
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
228
Acute Respiratory Failure-III
318
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
318
Acute Respiratory Failure-I
321
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
321


